The evaluation of risk factors for prolonged viral shedding during anti-SARS-CoV-2 monoclonal antibodies and long-term administration of antivirals in COVID-19 patients with B-cell lymphoma treated by anti-CD20 antibodyResearch Published on 2024-07-222024-09-05 Journal: BMC Infectious Diseases [Category] update2024, [키워드] anti-CD20 B-cell lymphoma Bendamustine COVID-19 persistent infection [DOI] 10.1186/s12879-024-09631-3 PMC 바로가기 [Article Type] Research
Disseminated tuberculosis after Polatuzumab‐Vedotin based chemoimmunotherapy in a patient with Burkitt’s lymphomaCase Report Published on 2024-05-072024-09-05 Journal: Clinical Case Reports [Category] update2024, [키워드] Bendamustine Burkitt's lymphoma polatuzumab vedotin Reactivation rituximab Tuberculosis [DOI] 10.1002/ccr3.8838 PMC 바로가기 [Article Type] Case Report
Prolonged SARS‐CoV ‐2 infection during obinutuzumab and bendamustine treatment for follicular lymphoma: A case reportCase Report Published on 2023-08-282024-09-05 Journal: Clinical Case Reports [Category] update2024, [키워드] Bendamustine COVID‐19 Follicular lymphoma obinutuzumab Prolonged infection SARS‐CoV‐2 severe acute respiratory syndrome coronavirus 2 [DOI] 10.1002/ccr3.7861 PMC 바로가기 [Article Type] Case Report
Infections associated with bendamustine and anti-CD20 antibody in untreated follicular lymphoma: a real-world studyShort Communication Published on 2023-07-282024-09-04 Journal: Journal of clinical and experimental hematopathology : JCEH [Category] 대상포진, [키워드] Anti-CD20 antibody Bendamustine cytomegalovirus Follicular lymphoma Infection [DOI] 10.3960/jslrt.23015 PMC 바로가기 [Article Type] Short Communication
Poor clinical outcome of relapsed/refractory diffuse large B-cell lymphoma with MYC translocation treated with polatuzumab vedotin, bendamustine, and rituximabShort Communication Published on 2023-07-282024-09-04 Journal: Journal of clinical and experimental hematopathology : JCEH [Category] 대상포진, [키워드] Bendamustine diffuse large B-cell lymphoma MYC translocation polatuzumab vedotin [DOI] 10.3960/jslrt.23017 PMC 바로가기 [Article Type] Short Communication
Persistent SARS-CoV-2 infection with multiple clinical relapses in two patients with follicular lymphoma treated with bendamustine and obinutuzumab or rituximabCase Report Published on 2023-04-192024-09-05 Journal: Infection [Category] update2024, [키워드] anti-CD20 Bendamustine COVID-19 immunosuppressed patient lymphoma obinutuzumab rituximab SARS-CoV-2 [DOI] 10.1007/s15010-023-02039-2 PMC 바로가기 [Article Type] Case Report
Prolonged COVID-19 in an Immunocompromised Patient Treated with Obinutuzumab and Bendamustine for Follicular LymphomaArticle Published on 2022-08-152022-11-15 Journal: Internal medicine (Tokyo, Japan) [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] anti-spike protein IgG Bendamustine coronavirus COVID-19 COVID-19 symptom COVID-19 symptoms detect Dexamethasone discharged exacerbated follicular Follicular lymphoma Immunocompromised Immunocompromised patient Immunocompromised patients lymphoma obinutuzumab obinutuzumab and bendamustine observation Patient Prolonged Prolonged COVID-19 Remdesivir SARS-CoV-2 vaccination subsequent Symptom the disease the patient treated [DOI] 10.2169/internalmedicine.9136-21 PMC 바로가기
Prolonged shedding of infectious viruses with haplotype switches of SARS-CoV-2 in an immunocompromised patient면역 저하 환자에서 SARS-CoV-2의 일배체형 스위치로 감염성 바이러스의 장기간 배출Case Reports Published on 2022-07-012022-09-11 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), MERS, SARS, 변종, 진단, 치료기술, [키워드] accumulated acquired immunity Bendamustine Clinical course Complete Complete Remission convalescent stage COVID-19 COVID-19 case COVID-19 infection COVID-19 pneumonia detectable eight episode episode of follicular Follicular lymphoma Haplotype Host immune Immunity Immunocompromised Immunocompromised host Immunocompromised patient Infectious virus infectiousness Infectivity initial kinetic long-lasting lymphoma management mechanical ventilation Non-synonymous mutation Patient Pneumonia Prolonged raised required Respiratory failure rituximab SARS-CoV-2 SARS-CoV-2 variants spike gene suppressed tested the SARS-CoV-2 variants Viral Viral kinetic. Viral RNA [DOI] 10.1016/j.jiac.2022.04.004 PMC 바로가기 [Article Type] Case Reports
Persistent viral shedding of severe acute respiratory syndrome coronavirus 2 after treatment with bendamustine and rituximab: A case report벤다무스틴과 리툭시맙 치료 후 중증급성호흡기증후군 코로나바이러스 2의 지속적인 바이러스 배출: 증례 보고Case Reports Published on 2022-06-012022-09-11 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), SARS, 변종, 진단, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus Admission Bendamustine Case report Chain Reaction Chemotherapy chemotherapy session chronic disease Chronic diseases condition coronavirus coronavirus disease COVID-19 detectable discharged eight FIVE follicular Follicular lymphoma hospital initiated lymphopenia N501Y nasopharyngeal specimen nine NPs on admission Patient patients persistent persistent infection polymerase chain polymerase chain reaction positive receive receiving respiratory rituximab RNA SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 tested the patient the SARS-CoV-2 therapy Treatment variant Viral viral shedding [DOI] 10.1016/j.jiac.2022.01.014 PMC 바로가기 [Article Type] Case Reports
Time to Onset of Bendamustine-associated Skin Damage Using the Spontaneous Reporting System벤다무스틴 관련 피부 손상의 발현 시간: 자발적 보고 시스템을 이용하여Article Published on 2022-05-012023-06-02 Journal: Anticancer research [Category] 대상포진, 두창, 홍역, [키워드] Bendamustine Japanese Adverse Drug Reaction Reporting Database skin damage time to onset. [DOI] 10.21873/anticanres.15752